IS6653A - Ný blanda sem felur í sér betatálma og mögulega kólesteróllækkandi efni - Google Patents

Ný blanda sem felur í sér betatálma og mögulega kólesteróllækkandi efni

Info

Publication number
IS6653A
IS6653A IS6653A IS6653A IS6653A IS 6653 A IS6653 A IS 6653A IS 6653 A IS6653 A IS 6653A IS 6653 A IS6653 A IS 6653A IS 6653 A IS6653 A IS 6653A
Authority
IS
Iceland
Prior art keywords
inhibitors
blend containing
containing beta
new blend
lowering substances
Prior art date
Application number
IS6653A
Other languages
English (en)
Inventor
Berglund Göran
Wikstrand John
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS6653A publication Critical patent/IS6653A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pyrrole Compounds (AREA)
IS6653A 2000-06-22 2002-12-11 Ný blanda sem felur í sér betatálma og mögulega kólesteróllækkandi efni IS6653A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0002354A SE0002354D0 (sv) 2000-06-22 2000-06-22 New formulation
PCT/SE2001/001380 WO2001097751A2 (en) 2000-06-22 2001-06-15 New formulation comprising a betablocker and optionally a cholesterol-lowering agent

Publications (1)

Publication Number Publication Date
IS6653A true IS6653A (is) 2002-12-11

Family

ID=20280209

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6653A IS6653A (is) 2000-06-22 2002-12-11 Ný blanda sem felur í sér betatálma og mögulega kólesteróllækkandi efni

Country Status (28)

Country Link
US (2) US20030191177A1 (is)
EP (1) EP1296716B1 (is)
JP (1) JP2003535875A (is)
KR (1) KR20030010750A (is)
CN (1) CN1437484A (is)
AR (1) AR028699A1 (is)
AT (1) ATE344675T1 (is)
AU (1) AU2001274766A1 (is)
BG (1) BG107373A (is)
BR (1) BR0111790A (is)
CA (1) CA2411100A1 (is)
CZ (1) CZ20024181A3 (is)
DE (1) DE60124400T2 (is)
EE (1) EE200200703A (is)
ES (1) ES2274892T3 (is)
HK (1) HK1054508A1 (is)
HU (1) HUP0302371A3 (is)
IL (1) IL153245A0 (is)
IS (1) IS6653A (is)
MX (1) MXPA02012957A (is)
NO (1) NO20026177L (is)
NZ (1) NZ523188A (is)
PL (1) PL360484A1 (is)
RU (1) RU2271802C2 (is)
SE (1) SE0002354D0 (is)
SK (1) SK18072002A3 (is)
WO (1) WO2001097751A2 (is)
ZA (1) ZA200209908B (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007512347A (ja) * 2003-11-26 2007-05-17 デューク・ユニバーシティー 緑内障を予防するかまたは治療する方法
KR100582347B1 (ko) * 2004-12-30 2006-05-22 한미약품 주식회사 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
KR100836321B1 (ko) 2006-10-31 2008-06-09 현대자동차주식회사 차량용 모니터 장치
US8703178B2 (en) * 2007-03-08 2014-04-22 Nitto Denko Corporation Percutaneous administration device of bisoprolol

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175187A (en) * 1989-03-06 1992-12-29 Soorianarain Baligadoo Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof
US5455269A (en) * 1989-03-06 1995-10-03 Baligadoo; Soorianarain Synergistic compositions of amiodarone and beta blockers
CA2106494A1 (en) * 1991-03-18 1992-09-19 James W. Young Composition and method containing optically pure (s) metoprolol
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
NO177455C (no) * 1993-06-04 1995-09-20 Gerrit Elmenhorst Anordning ved apparat for fremstilling av brannslukkende skum
JP2000508659A (ja) * 1996-04-17 2000-07-11 メルク エンド カンパニー インコーポレーテッド 心血管疾患関連の危険性を低減する組み合わせ療法
SE9602762D0 (sv) * 1996-07-12 1996-07-12 Astra Ab Carton and blank for forming the same
US5998458A (en) * 1997-06-25 1999-12-07 University Technology Corporation Method of treating heart failure
GT199800126A (es) * 1997-08-29 2000-01-29 Terapia de combinacion.
DE69911058T2 (de) * 1998-12-23 2004-06-03 G.D. Searle Llc, Chicago Kombinationen einem ibat inhibitor und einem mtp inhibitor für kardiovaskuläre indikationen

Also Published As

Publication number Publication date
RU2271802C2 (ru) 2006-03-20
ZA200209908B (en) 2004-03-05
EP1296716A2 (en) 2003-04-02
WO2001097751A2 (en) 2001-12-27
CN1437484A (zh) 2003-08-20
NO20026177D0 (no) 2002-12-20
IL153245A0 (en) 2003-07-06
EE200200703A (et) 2004-08-16
AU2001274766A1 (en) 2002-01-02
HUP0302371A2 (hu) 2003-11-28
DE60124400T2 (de) 2007-10-31
BR0111790A (pt) 2003-05-20
EP1296716B1 (en) 2006-11-08
US20030191177A1 (en) 2003-10-09
WO2001097751A3 (en) 2002-03-28
HUP0302371A3 (en) 2007-03-28
BG107373A (bg) 2003-09-30
NO20026177L (no) 2002-12-20
AR028699A1 (es) 2003-05-21
MXPA02012957A (es) 2003-05-15
KR20030010750A (ko) 2003-02-05
JP2003535875A (ja) 2003-12-02
SK18072002A3 (sk) 2003-08-05
ES2274892T3 (es) 2007-06-01
SE0002354D0 (sv) 2000-06-22
DE60124400D1 (de) 2006-12-21
CA2411100A1 (en) 2001-12-27
ATE344675T1 (de) 2006-11-15
PL360484A1 (en) 2004-09-06
US20060252814A1 (en) 2006-11-09
HK1054508A1 (zh) 2003-12-05
NZ523188A (en) 2006-06-30
CZ20024181A3 (cs) 2003-04-16

Similar Documents

Publication Publication Date Title
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
IL146904A0 (en) Gypsum compositions and related methods
EP1313477A4 (en) COMPILATIONS AND METHODS
GB0028041D0 (en) Expander
AU2001287180A1 (en) Microarray detector and synthesizer
SI1251848T1 (en) Gyrase inhibitors and uses thereof
EP1274424A4 (en) CONNECTIONS AND PROCEDURE
GB0026598D0 (en) Improved drilling methods and apparatus
AU4163402A (en) Composition and method
AU6392701A (en) Piperazine and piperidine compounds
GB2382608B (en) Well packer and method
IS6693A (is) Ný efnasambönd og notkun þeirra sem glýsín flutningshindra
IS6140A (is) Lyfjablanda sem inniheldur hemil karboxýpeptíðasaU og þrombínhemil
GB0016943D0 (en) Drills and their manufacture
AU4039201A (en) A notepad and notepad holder
GB0005301D0 (en) Compound, composition and use
GB2373523B (en) Method and device for rotary well drilling
GB0019309D0 (en) Vane adjusted wingsail
WO2002012223A3 (en) SYNTHETIC SALICYLIHALAMIDES, APICULARENS AND DERIVATIVES THEREOF
AU5054501A (en) Acetyltransferase and uses thereof
GB0000859D0 (en) Oral stereotypies
GB0021437D0 (en) Word line test ability improvement
AU4396101A (en) Perforation detection method
AU7035601A (en) Novel compounds and methods
GB0029496D0 (en) Optipouch and optipad